KYMERA THERAPEUTICS, INC. Payments of Stock Issuance Costs
KYMERA THERAPEUTICS, INC. (KYMR) reported Payments of Stock Issuance Costs of $16.21 million for the 12-month period ending 2021-12-31, per its 10-K filed 2024-02-22.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2024-02-22
- KYMERA THERAPEUTICS, INC. payments of stock issuance costs for the quarter ending 2021-12-31 was $0.00.
- KYMERA THERAPEUTICS, INC. payments of stock issuance costs for the quarter ending 2021-09-30 was $16.21M, a 4.68% decline year-over-year.
- KYMERA THERAPEUTICS, INC. payments of stock issuance costs for the quarter ending 2020-12-31 was $0.00.
- KYMERA THERAPEUTICS, INC. payments of stock issuance costs for the quarter ending 2020-09-30 was $17.00M.
- KYMERA THERAPEUTICS, INC. payments of stock issuance costs for fiscal 2021 was $16.21M, a 4.68% decline from fiscal 2020.
- KYMERA THERAPEUTICS, INC. payments of stock issuance costs for fiscal 2020 was $17.00M.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $16.21M derived: sum of 2 quarters · filed 2024-02-22 | $16.21M 10-K · filed 2024-02-22 | |
| 2021-09-30 | $16.21M 10-Q · filed 2022-11-03 | $16.21M 10-Q · filed 2022-11-03 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $17.00M derived: sum of 2 quarters · filed 2023-02-23 | $17.00M 10-K · filed 2023-02-23 | |
| 2020-09-30 | $17.00M 10-Q · filed 2021-11-10 | $17.00M 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |